The starting material was Arabica coffee grounds collected from a local coffee shop, dried to about five percent moisture and defatted with n-hexane. Coffee grounds are carbohydrate-rich, with carbohydrates representing 57 to 82 percent of the dry matter depending on the coffee source and processing conditions. These carbohydrates exist mainly as polysaccharides such as cellulose, hemicellulose, pectin, and galactomannans. The researchers used an alkaline extraction method, mixing the dried grounds with sodium hydroxide solution at a solid-to-liquid ratio of 1:20 and heating to 95 °C for three hours at four different pH values: 8, 9, 10, and 11. After centrifugation, concentration, ethanol precipitation, dialysis, and lyophilization, the team obtained polysaccharide–protein composite powders that spontaneously form nanoparticles in water.

Extraction pH proved decisive. The product yield increased significantly with increasing alkalinity, reaching 7.00 ± 0.64 percent at pH 11, as alkali more effectively disrupted the cell wall structure and released more polysaccharide molecules. Total sugar content peaked at pH 9 with 53.26 ± 2.64 percent, but protein content climbed steadily to 19.56 ± 1.34 percent at pH 11. Galactose was the predominant monosaccharide in all samples, reaching 62.52 percent at pH 11, confirming that the extracted polysaccharides originate primarily from cell-wall hemicellulose. The weight-average molecular weight also increased with pH, from 8.95 kDa at pH 8 to 15.28 kDa at pH 11, because hydroxide ions hydrolyze acetyl and glycosidic bonds in hemicellulose, liberating higher-molecular-weight components.

Structural analysis revealed that all samples were amorphous, with no obvious crystalline diffraction peaks in X-ray diffraction patterns. Fourier-transform infrared spectroscopy showed characteristic carbohydrate bands near 3469 and 2926 cm⁻¹, assigned to OH and CH stretching vibrations, with more intense carboxylate bands in the pH 10 and 11 samples, consistent with higher glucuronic acid content. Thermogravimetric analysis showed that the weight-loss rate decreased as extraction pH increased, attributed to removal of low-molecular-weight compounds and formation of carboxylate salts, which enhanced thermal stability.

In water, the composites existed mainly as nanoparticles ranging from 200 to 250 nanometers, with all particles exhibiting negative zeta potentials. The pH 11 sample, labeled CPP-11, showed a significantly more negative charge than the others, attributed to its higher protein content. Contact angle measurements revealed that all particles were hydrophobic, with contact angles greater than 90°, and hydrophobicity increased with extraction pH, reflecting greater exposure of hydrophobic protein groups under strongly alkaline conditions. Dynamic interfacial tension measurements at air/water, fish oil/water, and soybean oil/water interfaces showed that the composites gradually adsorbed and rearranged to form stable interfacial layers, with the pH 11 sample forming interfaces more resistant to deformation.

Emulsifying performance was evaluated with soybean oil and fish oil emulsions. All composites stabilized emulsions with good physical stability, showing no significant changes in droplet size within seven days of storage. Increasing composite concentration gradually decreased emulsion droplet size, attributed to better interfacial tension reduction and formation of a thicker layer on droplet surfaces. Considering yield, surface charge, and storage stability collectively, the researchers selected CPP-11 for flavor-loading experiments with six commercial flavor products: menthol, vanilla bean flavor, vanillin, geraniol, cocoa flavor extract, and vanilla extract.

The six flavor emulsions, labeled D1 through D6, had particle sizes ranging from 560 to 645 nanometers. The cocoa flavor extract formulation, D5, showed excellent physical stability over the seven-day storage period, with particle size changing from 572.41 ± 98.45 to 477.62 ± 25.64 nanometers without statistical significance, and absolute zeta potential increasing from 30.05 ± 0.68 to 31.67 ± 0.25 mV. Scanning electron microscopy of the lyophilized powders revealed that the composite alone exhibited a sheet-like morphology with rough, heterogeneous surfaces, while the flavor-loaded powder showed a more compact, quasi-spherical morphology with smoother edges, indicating enhanced intermolecular interactions within the system.

Antioxidant activity after heating was striking. After thermal treatment at 80 °C, the composite-stabilized cocoa flavor formulation exhibited a DPPH radical-scavenging activity of 30.21 ± 0.55 percent, compared with 9.20 ± 0.57 percent for free cocoa flavor and 13.65 ± 0.19 percent for the composite alone. This substantially higher activity was not simply additive, suggesting the carrier system helps preserve functional properties during thermal processing.

Headspace solid-phase microextraction gas chromatography–mass spectrometry revealed that the nanoparticles themselves contained multiple volatile compounds, including 2-methoxy-4-vinylphenol, phenylethyl phenylacetate, cinnamaldehyde, 2,4-di-tert-butylphenol, and vanillin. The high abundance of vanillin may result from degradation of lignin in the coffee grounds. These compounds contribute smoky, spicy, warm cinnamon-like, floral, and honey-like aroma notes. The flavor-loaded formulation exhibited a more diverse volatile profile, combining intrinsic coffee-derived volatiles with compounds introduced by the cocoa extract. Storage temperature shifted the aroma profile: at 4 °C, 2-methoxy-4-vinylphenol dominated the composite, whereas vanillin increased at 45 °C, shifting from phenolic and smoky notes toward a sweeter, vanilla-like character.

Pyrolysis–gas chromatography–mass spectrometry at 200, 275, and 350 °C demonstrated the thermal resilience of the encapsulated flavors. At 200 °C, the flavor-loaded powder was dominated by vanillin at 68.67 percent and propylene glycol at 23.99 percent, indicating the encapsulated cocoa flavor compounds remained largely intact and were gradually released rather than degraded. The bare nanoparticles, by contrast, generated substantial carbon dioxide, methyl stearate, and methyl hexadecanoate, marking initial decomposition of polysaccharide and lipid components. At 275 °C, the bare composites showed characteristic carbohydrate pyrolysis products including levoglucosan at 52.57 percent, while the flavor-loaded powder still retained detectable vanillin at 47.77 percent and 2-phenylethyl phenylacetate, suggesting interactions between flavor molecules and the polysaccharide–protein matrix delayed thermal degradation. At 350 °C, vanillin decreased to 24.29 percent as extensive fragmentation and secondary reactions took over.

The findings highlight the potential of naturally occurring polysaccharide–protein composites as multifunctional delivery systems integrating structural support, flavor protection, and thermally triggered aroma release. Beyond cocoa flavor, the nanoparticles could serve as carriers for lipophilic flavor and aroma compounds in tobacco products, bakery and confectionery items, instant beverage powders, and other emulsion-based or thermally processed foods. The authors note that product-specific sensory properties, processing stability, safety, and regulatory compliance should be evaluated before practical application. More importantly, the work demonstrates how waste-derived materials can be transformed into functional ingredients, turning the residue of the world’s favorite beverage into a vehicle for the flavors of tomorrow.

Subject of Research: Food Chemistry

Article Title: Endogenous polysaccharide–protein composite nanoparticles prepared from spent coffee grounds as multi-flavor carriers

Article References: Tao, H., Guan, W., Zhu, H., Han, Q., Dai, M., Gao, X., Lin, Y., & Zhang, Y. (2026). Endogenous polysaccharide–protein composite nanoparticles prepared from spent coffee grounds as multi-flavor carriers. Food Chemistry: X, Article 104636. https://doi.org/10.1016/j.fochx.2026.104636

Image Credits: AI Generated

DOI: 10.1016/j.fochx.2026.104636

Keywords: spent coffee grounds, nanoparticles, flavor encapsulation, Pickering emulsions, food waste valorization, pyrolysis, aroma release, Endogenous, polysaccharide, protein, composite, prepared

The intestinal barrier is a single layer of epithelial cells sealed by protein complexes known as tight junctions, which include zonula occludens-1 (ZO-1), occludin, and claudins. When these seals fail, bacteria and antigens slip into the underlying tissue, igniting the mucosal inflammation that drives inflammatory bowel disease, including ulcerative colitis and Crohn’s disease. Strategies that restore tight junction integrity are therefore a major goal of colitis research. Gut microbes contribute to barrier health largely through their metabolites, and in colitis a loss of protective bacteria such as Bacteroides, Roseburia, Lactobacillus, and Akkermansia is typically accompanied by reduced short-chain fatty acid production, starving the epithelium of energy and weakening junctional homeostasis. What has been missing, the authors argue, is a systematic map connecting a defined natural polysaccharide to a specific microbe, a specific metabolite, and a specific host signaling pathway.

To find that map, the team first fractionated hot-water extracts of G. applanatum fruiting bodies using anion-exchange and gel-filtration chromatography, yielding four purified fractions named GAP1 through GAP4 according to their salt elution order. When administered to mice with dextran sulfate sodium (DSS)-induced colitis, all fractions eased clinical signs such as weight loss, colon shortening, and disease activity index, but only GAP1 and GAP2 significantly modulated barrier-related proteins, suppressed the enzymes iNOS, MPO, and COX-2, lowered pro-inflammatory cytokines including IL-1β, IL-6, IL-17, and TNF-α, raised the anti-inflammatory cytokine IL-10, and improved histological appearance of the mucosa. Structural analysis by nuclear magnetic resonance and mass spectrometry revealed why the two winners might behave differently: GAP1 is a branched heteropolysaccharide rich in mannose, glucose, and galactose, whereas GAP2 is a comparatively simple linear β-glucan built from a repeating →3)-β-Glcp-(1→ backbone with an average molecular weight of about 2.05 × 10^4 Da.

The decisive experiment came from germ-free mice. When the polysaccharides were given directly to animals lacking a microbiome, they lost nearly all of their protective power, failing to prevent weight loss, colon shortening, or histological damage. Yet when the researchers transplanted fecal material from polysaccharide-treated donor mice into germ-free recipients, or gavaged those recipients with filtered, bacteria-free fecal metabolites, barrier protection returned in full, with restored ZO-1 and occludin expression and intact epithelial architecture. In other words, the polysaccharides themselves never touch the epithelium in a meaningful way; the true therapeutic agents are the microbes and metabolites that the polysaccharides cultivate. This postbiotic-inducing mechanism places GAP firmly in the emerging class of dietary compounds whose benefits are entirely microbiota-dependent.

When the team delayed treatment until after DSS injury had been established, to mimic patients who already have a damaged barrier, GAP2 outperformed GAP1 decisively, accelerating weight and colon-length recovery, preserving glandular structure, boosting mucus-producing cells, and elevating tight junction protein abundance. Because the two fractions have nearly identical molecular weights, the authors attribute the difference to their structures: GAP2’s unbranched β-glucan backbone is more bioavailable and more readily digested by the right bacteria, whereas side chains on GAP1 generally reduce polysaccharide degradability. Shotgun metagenomic sequencing of fecal samples showed that GAP2 restored microbial α-diversity and enriched beneficial genera including Bacteroides, Parabacteroides, Akkermansia, Alistipes, and members of the Lachnospiraceae and Oscillospiraceae. Machine-learning feature selection singled out one organism above all others: Phocaeicola vulgatus, a commensal colonizer present in up to 90 percent of the global human population.

Untargeted metabolomics then identified the chemical messenger. Among all differentially enriched metabolites, the odd-chain fatty acid tridecylic acid (C13:0) stood out, and it was the only fatty acid whose fecal concentration correlated significantly with P. vulgatus abundance in GAP2-treated mice. KEGG pathway analysis showed that GAP2 shifted the community toward fatty acid biosynthesis and related routes while downgrading virulence-associated features such as type IV pili, capsules, and lipopolysaccharide. To prove causation rather than correlation, the researchers grew P. vulgatus in pure culture with GAP2 as the sole carbon source. The bacterium grew on GAP2 as well as it grows on glucose, reaching an optical density of 0.75 at 24 hours, and qPCR showed GAP2 raised its absolute abundance roughly tenfold compared with GAP1, to about 10^9 CFU per milliliter, with tridecylic acid accumulating to the highest levels seen across any tested substrate, including inulin, xylan, arabinoxylan, mannan, and β-glucan.

Genome sequencing confirmed that P. vulgatus carries the complete fatty acid biosynthesis toolkit, including fabB, fabG, fabZ, fabK, and FatA, plus the GH16 hydrolase needed to cleave GAP2’s β-glucan backbone. Using a CRISPR-Cas system, the team built knockout mutants to close the loop. Deleting GH16 crippled the bacterium’s growth on GAP2, confirming the enzyme’s role in accessing the polysaccharide, while deleting fabB left growth intact but abolished tridecylic acid production, pinpointing the elongation step as the metabolic bottleneck. On the host side, transcriptomics of colon tissue from GAP2-treated mice revealed upregulation of the cell adhesion network, with elevated CDC42, Rho, BAIAP2, and Par3, and western blots confirmed increased ZO-1, occludin, and MUC2. In LPS-stressed Caco-2 epithelial cells, tridecylic acid alone reproduced the effect, restoring Rho, CDC42, and BAIAP2 expression and raising tight junction proteins, implicating the Rho/CDC42 pathway, which stabilizes the perijunctional actin cytoskeleton and promotes ZO-1 and occludin deposition, as the downstream target.

The clinical relevance received support from a large human metagenomic dataset covering 460 healthy controls and 575 ulcerative colitis patients. The UC cohort showed significantly reduced microbial diversity by Shannon and Chao1 indices and a distinct community composition, with P. vulgatus showing the largest drop of any taxon and emerging as a key discriminator between the groups. Critically, the abundance of genes in the tridecylic acid synthesis pathway, including fabB, fabG, fabZ, fabK, and FatA, was markedly reduced in UC patients, suggesting that the loss of this microbe-metabolite axis accompanies barrier breakdown in human disease. The authors caution that these human data are observational and lack direct metabolite measurements, so extrapolation to patients requires intervention trials and metabolomics in human systems.

The study also situates tridecylic acid within a broader pattern. Recent work has shown that Parabacteroides distasonis can produce pentadecanoic acid from inulin to ease non-alcoholic steatohepatitis, and that Bacteroides acidifaciens generates C15:0 when fed galacto-oligosaccharides alongside Limosilactobacillus reuteri, dampening NF-κB activation and strengthening tight junctions. Tridecylic acid itself has documented anti-inflammatory, anti-fibrotic, and anti-cancer activities through AMPK and PPAR-α/δ activation and inhibition of mTOR, JAK3-STAT1, and HDAC6, plus antimicrobial and anti-biofilm effects against Escherichia coli. Because every enzyme in its biosynthesis is encoded in the P. vulgatus genome, the authors suggest that genetic engineering or targeted regulatory switches could one day allow precise in vivo control of tridecylic acid production, in the same spirit as recent efforts to engineer P. vulgatus for oxalate degradation. For now, the findings establish a clean, testable model: a defined mushroom polysaccharide feeds a defined commensal, which makes a defined fatty acid that repairs the gut wall through a defined signaling pathway, giving researchers a blueprint for designing postbiotic-inducing dietary interventions for ulcerative colitis and related inflammatory mucosal disorders.

Subject of Research: Microbiota-dependent repair of intestinal barrier dysfunction in ulcerative colitis by a Ganoderma applanatum polysaccharide inducing tridecylic acid production in Phocaeicola vulgatus

Article Title: A Postbiotic‐Inducing Ganoderma applanatum Polysaccharide Repairs the Intestinal Barrier via a Phocaeicola vulgatus ‐ Tridecylic Acid Axis

Article References: Zhang, C., Li, M., Li, T., Zang, X., Shi, H., Liu, Y., Zhang, C., Zhao, J., Zhai, Q., Chen, W., & Tian, F. (2026). A Postbiotic‐Inducing Ganoderma applanatum Polysaccharide Repairs the Intestinal Barrier via a Phocaeicola vulgatus ‐ Tridecylic Acid Axis. Advanced Science, Article e78105. https://doi.org/10.1002/advs.78105

Image Credits: AI Generated

DOI: 10.1002/advs.78105

Keywords: Ganoderma applanatum, polysaccharide, ulcerative colitis, intestinal barrier, Phocaeicola vulgatus, tridecylic acid, postbiotic, gut microbiota, tight junctions, CDC42, Rho signaling, prebiotic

The story begins with a chemical problem. Polygonati rhizoma polysaccharide, or PRP, is the most abundant bioactive component of Huangjing and has previously been shown to reduce dopaminergic neuron loss, suppress oxidative stress, and temper microglial inflammation in models of Parkinson’s disease. But PRP is built mostly of glucose and fructose monosaccharides whose abundant hydroxyl groups form strong intramolecular hydrogen bonds. That makes the molecule poorly reactive in water and difficult to combine with drugs or biomaterials, limiting its use in drug delivery or tissue engineering. To unlock its potential, the team turned to controlled periodate oxidation, a strategy widely used to convert the vicinal diols of polysaccharides such as dextran, alginate, and hyaluronic acid into reactive aldehyde groups.

Treating PRP with sodium periodate yielded oxidized PRP, or OPRP, with a degree of oxidation of roughly 16.33 percent. Structural elucidation was exhaustive: proton and carbon NMR, two-dimensional NMR experiments including COSY, HSQC, HMBC, and NOESY, FTIR spectroscopy, methylation analysis, and monosaccharide composition together identified OPRP as an inulin neoseries-type fructan with a weight-average molecular weight of 4.6 kilodaltons. Fructose made up more than 93 percent of the monosaccharide content, the backbone was dominated by 1,2-linked fructose residues exceeding 55 percent, and a low dispersity ratio of 1.04 confirmed the purity of the isolated polysaccharide. FTIR revealed the characteristic carbonyl absorption at 1730 per centimeter, while furanose-specific peaks at 1016, 1115, 939, and 816 per centimeter confirmed the β-D-furanose fructose architecture.

With reactive aldehydes in hand, the researchers crosslinked OPRP with carboxymethyl chitosan through Schiff base reactions, the reversible condensation between aldehyde and amino groups that underlies many self-healing injectable hydrogels. The optimized formulation, containing 2.5 percent OPRP and 5 percent carboxymethyl chitosan, gelled within ten minutes and displayed a storage modulus of about 230 pascals, a stiffness squarely within the soft 0.1 to 1 kilopascal range considered favorable for neural tissue. Scanning electron microscopy revealed a uniform porous network with an average pore diameter near 45.4 micrometers and porosity of roughly 95.4 percent. Rheological testing showed the gel could withstand strains up to 370 percent before yielding, then fully recover its modulus after repeated damage-healing cycles. It flowed smoothly through a 30-gauge needle fine enough to write letters, and degraded slowly in saline, retaining about 34 percent of its mass after fourteen days.

The material’s drug delivery credentials were demonstrated with Fast Green FCF, a hydrophilic stand-in for levodopa, which diffused steadily from the gel over a fourteen-day dialysis experiment before reaching a plateau around day ten. But the more provocative finding concerns what the gel does without any drug at all. In free radical scavenging assays, drug-free COPRP clearly outperformed a bioinert control hydrogel made from carboxymethyl chitosan and a dibenzaldehyde-terminated polyethylene glycol crosslinker, and adding levodopa more than doubled the scavenging capacity, an effect attributed to the polyphenolic chemistry of the drug itself. The authors are careful to frame the levodopa-loaded version, COPRPL, not as a simple carrier-drug relationship but as a deliberate dual-mechanism design in which the OPRP backbone remodels the diseased brain microenvironment while levodopa replenishes dopaminergic signaling.

In cellular experiments, the team challenged BV2 microglia with lipopolysaccharide to provoke inflammation and reactive oxygen species. Hydrogels containing OPRP significantly reduced ROS fluorescence, cut the M1-type pro-inflammatory markers IL-1β, iNOS, and TNF-α by more than 40 percent, and raised the M2-type anti-inflammatory marker CD206 by over 1.8-fold, with the levodopa-loaded gel pushing that upregulation past threefold. In a human neuroblastoma SH-SY5Y model of Parkinsonian injury induced by 6-hydroxydopamine, COPRP restored cell viability, reduced early and late apoptosis, rescued mitochondrial membrane potential as measured by JC-1 staining, and preserved expression of tyrosine hydroxylase, the rate-limiting enzyme of dopamine synthesis. The bioinert control gel did none of this, isolating the benefit to the OPRP component.

The in vivo results were the most consequential. The researchers lesioned the medial forebrain bundle of Sprague Dawley rats with 6-hydroxydopamine, confirmed successful Parkinsonian induction in about 94 percent of animals by apomorphine-evoked rotation, then injected four microliters of saline, inert hydrogel, COPRP, or COPRPL stereotaxically into the lesion site. By day seven, COPRP-treated rats were already rotating significantly slower than controls, and by day fourteen their circling speed had fallen to roughly 8.2 seconds per round. In the cylinder test, forelimb contact rates on the impaired side recovered by more than 15 percent in OPRP-gel groups and over 22 percent with levodopa loading, while open-field testing showed increased locomotion and exploration. Histology confirmed the pattern: more tyrosine hydroxylase-positive dopaminergic neurons survived in the substantia nigra, activated Iba1-positive microglia and GFAP-positive astrocytes were markedly reduced, and cerebral superoxide dismutase activity rose to approximately 53 units per milligram of tissue in the levodopa-loaded group.

To find the mechanism, the team compared brain proteomes of inert-hydrogel and COPRP-treated rats using data-independent acquisition mass spectrometry on a timsTOF HT platform. Principal component analysis cleanly separated the groups, and differential expression identified 161 upregulated and 38 downregulated proteins. KEGG enrichment pointed to focal adhesion, sphingolipid signaling, axon guidance, Rap1 signaling, and neurotrophin pathways, with selective remodeling of extracellular matrix components such as the Col6a collagens, paxillin, and talin. Critically, gene set enrichment analysis confirmed significant upregulation of the entire TGF-β signaling pathway. Western blotting then verified that COPRP increased TGF-β1 and TGF-β2 protein abundance, raised total Smad2/3, and markedly enhanced its phosphorylated form, the signature of pathway activation. Unexpectedly, GFAP expression fell rather than rose, leading the authors to propose that COPRP guides astrocytes away from a chronically hyperactivated, potentially neurotoxic phenotype toward a protective, repair-oriented state.

The causal test came from pirfenidone, an antifibrotic agent that attenuates TGF-β-associated signaling. Rats pretreated with pirfenidone before lesioning and COPRP treatment showed substantially reversed TGF-β2 expression and Smad2/3 phosphorylation, and their behavioral recovery across rotational, cylinder, and open-field tests was significantly blunted, though still better than untreated Parkinsonian rats. The authors acknowledge the limits of this design: systemic pirfenidone given before modeling cannot isolate striatal TGF-β signaling, so the data support the pathway as an important mediator without establishing pathway-specific causality. They also note that the study could not establish clinical or pharmacoeconomic advantages over established levodopa regimens, since the current approach requires stereotactic intracranial administration and specialized biomaterial preparation. Long-term biosafety, biodistribution of degradation products, and cell-type-specific knockout models to pinpoint the cellular targets of COPRP-mediated neuroprotection remain future work. Still, the framework is clear: a structurally defined fructan from a traditional medicinal herb, chemically functionalized into an injectable self-healing matrix, can couple local drug release with active immunomodulation and neuroprotection, positioning polysaccharide hydrogels as bioactive therapeutic agents rather than passive depots in the fight against neurodegeneration.

Subject of Research: A bioactive oxidized Polygonati rhizoma polysaccharide crosslinked chitosan hydrogel that modulates TGF-β/Smad signaling for Parkinson's disease treatment

Article Title: Modulation of the TGF‐β/Smad Signaling Pathway by a Bioactive Oxidized Polygonati Rhizoma Polysaccharide Crosslinked Chitosan Hydrogel as Therapeutic Carrier for Parkinson's Disease Treatment

Article References: Dai, P., Zhao, J., Xue, C., Xu, K., Yong, L., Zhang, Z., Huang, Y., Shuai, J., Chen, X., Nie, S., & Xu, J. (2026). Modulation of the TGF‐β/Smad Signaling Pathway by a Bioactive Oxidized Polygonati Rhizoma Polysaccharide Crosslinked Chitosan Hydrogel as Therapeutic Carrier for Parkinson's Disease Treatment. Advanced Science, Article e77842. https://doi.org/10.1002/advs.77842

Image Credits: AI Generated

DOI: 10.1002/advs.77842

Keywords: Parkinson's disease, hydrogel, Polygonatum sibiricum, polysaccharide, TGF-β/Smad signaling, levodopa, neuroinflammation, oxidative stress, Schiff base reaction, dopaminergic neurons, proteomics, drug delivery

The molecule, designated PKP, was isolated from dried rhizomes by hot-water extraction and ethanol precipitation, yielding nearly 36 grams of material from 200 grams of root with a carbohydrate purity of 99.4 percent. Structural characterization using high-performance gel permeation chromatography, monosaccharide analysis, and two-dimensional nuclear magnetic resonance revealed a mixed-type fructan with an average molecular weight of about 3.0 kilodaltons. Its backbone is composed overwhelmingly of fructose, 91.3 percent, linked through a combination of β-2,1 and β-2,6 fructofuranose bonds in a ratio of roughly 2.5 to 1, with smaller amounts of glucose and mannose and terminal α-glucopyranose units capping the chain. That architecture, the team reasoned, might allow the polysaccharide to interact with bacterial membranes while also serving as a recognizable signal to the mammalian immune system.

In laboratory assays, PKP proved markedly more potent against Gram-positive S. aureus than against Gram-negative Escherichia coli. The minimum inhibitory concentration against S. aureus was 400 milligrams per milliliter, and the minimum bactericidal concentration was 700 milligrams per milliliter, a ratio of 1.75 that formally classifies the compound as bactericidal rather than merely bacteriostatic. At that MIC, PKP killed 89.8 percent of S. aureus cells, with killing rates of 73.2 and 82.6 percent at 200 and 300 milligrams per milliliter respectively. E. coli proved far more stubborn, requiring concentrations up to 600 milligrams per milliliter to reach a killing rate of 72.1 percent. The researchers attribute this differential susceptibility to the outer membrane, selective porin channels, and powerful tripartite efflux pumps that shield Gram-negative bacteria from large, negatively charged molecules, whereas the teichoic-acid-rich envelope of Gram-positive organisms may offer PKP more accessible binding targets.

Time-kill kinetics added an important nuance. At the MIC, PKP held S. aureus growth flat for the first twelve hours, but optical density readings crept upward after the sixteen-hour mark, indicating a transient bacteriostatic effect that gradually waned. Doubling the concentration to 800 milligrams per milliliter abolished growth entirely across the full 24-hour observation window, a pattern typical of membrane-active agents whose killing accelerates sharply with concentration. The authors are candid about a limitation here: at such high polysaccharide concentrations, viscosity and osmotic pressure could contribute to apparent growth suppression, and they recommend future experiments with an inert high-molecular-weight control such as dextran to fully separate specific antimicrobial action from nonspecific physical effects.

Perhaps the most striking laboratory result concerned biofilms, the slimy, matrix-encased bacterial communities that make chronic S. aureus infections so notoriously resistant to antibiotics. Biofilm-embedded bacteria can tolerate antimicrobials at concentrations ten to a thousand times higher than their free-swimming counterparts, which is a principal reason chronic rhinosinusitis so often defeats conventional therapy. Yet when mature 36-hour S. aureus biofilms were challenged with PKP for 48 hours, crystal violet staining showed a steep, concentration-dependent collapse in biomass. Half the MIC left 74 percent of the biofilm intact, the MIC cut it to 52.6 percent, and twice the MIC reduced it to just 13.1 percent of control levels, an effect the authors describe as near-complete eradication. The steepness of that dose-response hints at a threshold mechanism, possibly saturation of the extracellular polymeric matrix or membrane disruption triggered only once a critical polysaccharide concentration is reached within the biofilm microenvironment.

To test whether any of this mattered in a living body, the team induced chronic rhinosinusitis in rats by placing S. aureus-soaked sponges in the nasal cavity and administering repeat bacterial instillations twice weekly for three weeks. All 60 animals modeled successfully, and the 24 most severely symptomatic rats were randomized to receive daily intranasal treatment with PKP at 200, 400, or 600 milligrams per milliliter for 14 days, alongside untreated infected and healthy control groups. The dose selection was deliberately grounded in translational math: converting the mid-dose of 177.8 milligrams per kilogram to a human equivalent dose using body-surface-area factors yields roughly 28.8 milligrams per kilogram, or about 1.73 grams of PKP per day for a 60-kilogram adult. Given the 17.96 percent extraction yield, that would require approximately 9.6 grams of dried herb, comfortably within the range of traditional daily intakes.

The histopathology told a clear story. Untreated infected rats showed dense neutrophilic infiltration in the sinus mucosa, averaging 139 neutrophils per high-power field, along with fibrous tissue hyperplasia, focal necrosis, and abscess formation. The lowest PKP dose barely moved the needle, but the 400 and 600 milligram-per-milliliter groups dropped infiltration to 55 and 34 neutrophils per high-power field respectively, with abscesses disappearing entirely at both higher doses. Cytokine profiling reinforced the picture: serum interleukin-6, a key driver of neutrophilic inflammation and tissue remodeling in chronic rhinosinusitis, fell significantly at the highest dose, while interleukin-22, a cytokine that maintains epithelial barrier integrity and stimulates antimicrobial peptide production, rose dose-dependently from depressed infection levels back toward healthy baseline values at 600 milligrams per milliliter.

Hematological analysis extended the findings to the whole animal. Infected rats treated with PKP showed leukocyte counts falling from 11.47 to roughly 6.5 × 10⁹ per liter, lymphocyte counts dropping from 9.23 to between 4.28 and 4.63 × 10⁹ per liter, and neutrophil counts declining as well, all pointing to a dampening of systemic inflammatory activation. Spleen and thymus indices rose relative to the untreated infected group, suggesting restored immune organ function, and total cholesterol declined modestly, hinting at metabolic effects the authors say warrant further study. Crucially, a parallel safety experiment in healthy, uninfected rats receiving identical intranasal regimens found no mucosal irritation, no significant changes in cytokine levels, and no disruption of red cells, platelets, hemoglobin, or most white cell parameters, with all values remaining within normal physiological ranges.

That last result may be the study’s most conceptually important contribution. Because PKP left the immune systems of healthy animals untouched while powerfully rebalancing the dysregulated immunity of infected ones, the compound appears to act through context-dependent immunomodulation rather than blunt stimulation or suppression. The authors are appropriately careful about the limits of their evidence: they did not directly quantify residual bacterial loads in the infected sinuses, so they frame the therapeutic benefit as a combined direct antibacterial and host-mediated effect rather than claiming definitive bacterial eradication. Testing against clinical isolates, including MRSA strains, and against a broader panel of Gram-positive and Gram-negative pathogens remains to be done, as does direct visualization of how PKP penetrates biofilm architecture.

Even with those caveats, the work bridges a gap that stalls many natural-product candidates: the leap from promising petri-dish data to demonstrable efficacy in a physiologically relevant disease model. A plant-derived fructan that kills planktonic S. aureus, erodes established biofilms, suppresses pathological interleukin-6 signaling, restores barrier-protective interleukin-22, and does so at doses achievable from ordinary quantities of a traditional herb, delivered by a route suitable for topical nasal therapy, offers a genuinely dual-pronged template for anti-infective development. If future studies confirm bacterial clearance in tissue and extend the findings to drug-resistant clinical strains, this humble Solomon’s seal relative could move from the apothecary shelf toward the front line of the resistance crisis.

Subject of Research: Antibacterial and immunomodulatory effects of a Polygonatum kingianum polysaccharide against Staphylococcus aureus infection

Article Title: Antibacterial and Immunomodulatory Activities of a Natural Polysaccharide Against Staphylococcus aureus Infection

Article References: Xia, X.-C., Peng, Y.-Q., Liu, L.-X., Cao, B., Zhong, X.-K., Wu, X.-D., & Liu, T. (2026). Antibacterial and Immunomodulatory Activities of a Natural Polysaccharide Against Staphylococcus aureus Infection. Food Science & Nutrition, 14(10), Article e72411. https://doi.org/10.1002/fsn3.72411

Image Credits: AI Generated

DOI: 10.1002/fsn3.72411

Keywords: Polygonatum kingianum, polysaccharide, fructan, Staphylococcus aureus, antimicrobial resistance, biofilm, chronic rhinosinusitis, immunomodulation, interleukin-6, interleukin-22, natural products, MRSA

The team began by purifying GEP from dried Gastrodia elata collected in Xiaocaoba, Zhaotong City, using hot-water extraction followed by ethanol precipitation and deproteinization. Chemical characterization revealed a remarkably pure preparation: total sugar content reached 90.04 percent, while protein contamination was a mere 1.72 percent. High-performance gel permeation chromatography showed a single symmetric peak corresponding to an average molecular weight of about 314 kilodaltons, placing GEP firmly in the category of large macromolecular polysaccharides. Monosaccharide analysis identified glucose as the dominant building block, and Fourier transform infrared spectroscopy confirmed a classic α-glucopyranose architecture, with absorption peaks marking hydroxyl stretching, pyranose ring vibrations, and α-glycosidic bonds. These structural details matter because the size, composition, and linkage chemistry of a polysaccharide determine how gut bacteria ferment it and which microbial species thrive on it.

With the molecule characterized, the researchers turned to cellular models. They exposed BV2 microglial cells, the resident immune cells of the brain, to d-galactose, a sugar widely used to induce senescence in laboratory settings. After 24 hours, cell viability fell in a concentration-dependent manner, with 200 millimolar d-galactose cutting viability roughly in half. Staining for senescence-associated β-galactosidase, a standard molecular marker of aged cells, confirmed that the treatment had pushed the microglia into a senescent state. When the team co-treated the cells with graded doses of GEP, the polysaccharide reversed the viability loss and significantly reduced the fraction of senescent cells, with 40 micrograms per milliliter showing the strongest effect. Senescent microglia are considered a central driving force of brain aging because they fuel chronic neuroinflammation, so rescuing them from senescence is a meaningful therapeutic signal.

The next test was one of the most demanding in aging biology: lifespan extension in Caenorhabditis elegans. Synchronized nematodes were raised from the first larval stage on plates containing 0.25, 0.5, or 1.0 milligram per milliliter of GEP. Because many plant polysaccharides have antibacterial properties that could indirectly extend lifespan by restricting the worms’ bacterial food supply and triggering caloric restriction, the researchers used heat-inactivated Escherichia coli OP50 as a uniform food source across all groups, carefully excluding this confounding pathway. Survival was tracked daily, and Kaplan–Meier analysis showed that GEP significantly prolonged average lifespan, with the 0.5 milligram per milliliter dose performing best. The result established that the anti-senescence activity seen in cells translates into a whole-organism longevity benefit.

The centerpiece of the study, however, was a natural aging model in mice, which avoids the artificialities of chemically induced senescence. Seventy-five eighteen-month-old male C57BL/6J mice were divided into groups receiving vehicle, vitamin E as a positive control, or GEP at 100, 200, or 400 milligrams per kilogram by daily oral gavage for two months, alongside fifteen two-month-old young controls. After the treatment period, the animals faced a battery of behavioral challenges. In the Morris water maze, aging mice took significantly longer to locate a hidden platform during five days of navigation training, and in the probe trial they spent less time in the target quadrant and crossed the platform position fewer times. Medium- and high-dose GEP shortened escape latencies and restored probe performance, with the medium dose showing the most pronounced improvement. Nest building, a sensitive index of social and autonomous function, was similarly depressed in aged mice and restored by GEP. Grip strength and wire-mesh climbing endurance, both of which decline with age, also rebounded under GEP treatment.

Histology explained the behavioral rescue. Hematoxylin–eosin staining of the hippocampus revealed that aging had disordered the neurons, shrunken their nuclei, and increased the number of damaged cells, while GEP preserved normal neuronal morphology and arrangement. Immunohistochemistry showed that GEP upregulated brain-derived neurotrophic factor, or BDNF, a core factor for neuronal survival and synaptic plasticity whose expression drops in the aging hippocampus. Notably, the medium dose of 200 milligrams per kilogram outperformed both the high dose and vitamin E across behavioral, histological, and molecular endpoints, producing a consistent inverted U-shaped dose–response curve. The authors suggest that excessively high polysaccharide concentrations may mildly overstimulate innate immune signaling in the gut, partially counteracting the compound’s own antioxidant and anti-inflammatory benefits, though they acknowledge this hypothesis requires further validation.

The molecular analysis traced the benefits to two canonical signaling axes. In serum and brain tissue, aging mice showed elevated malondialdehyde, a lipid peroxidation marker of oxidative damage, alongside reduced activities of the antioxidant enzymes superoxide dismutase and catalase. GEP reversed all three indicators. Western blotting revealed the mechanism: aging increased the expression of Keap1, the cytosolic protein that tags the transcription factor Nrf2 for degradation, and suppressed the downstream antioxidant enzymes HO-1 and NQO1. GEP downregulated Keap1 and restored HO-1 and NQO1, reactivating the Nrf2/Keap1 antioxidant defense system. Total Nrf2 protein levels were unchanged across groups, which the authors note is consistent with the pathway’s canonical regulation, since Nrf2 activation depends on nuclear translocation rather than increased total abundance, and the robust rise in downstream enzymes provides functional proof of pathway activation.

On the inflammatory side, the researchers measured the cytokines IL-1β, IL-6, and TNF-α by enzyme-linked immunosorbent assay and found them significantly elevated in both serum and brain of aged mice, the systemic fingerprint of inflammaging. The TLR4/NF-κB pathway, which drives this inflammatory transcription program, was correspondingly overactive, with increased TLR4 expression and heightened phosphorylation of the NF-κB subunit P65. GEP treatment suppressed TLR4 and reduced P65 phosphorylation, cutting the release of pro-inflammatory cytokines and breaking the vicious cycle in which oxidative stress fuels inflammation and inflammation in turn generates more reactive oxygen species.

The gut microbiota data tied the whole story together. Sixteen S ribosomal RNA sequencing of fecal samples showed that aging significantly reduced α-diversity and shifted the overall microbial composition away from that of young mice, as confirmed by principal coordinate analysis. At the phylum level, aging increased Bacteroidota and Pseudomonadota while depleting Bacillota and Verrucomicrobiota; at the genus level, beneficial taxa such as Lactobacillus and Dubosiella fell sharply, Akkermansia declined modestly, and Blautia was abnormally enriched. GEP reversed each of these shifts, restoring diversity and pushing the microbial profile of aged mice back toward the young control pattern. Critically, immunofluorescence of colon tissue showed that aging depleted the tight junction proteins ZO-1 and Occludin, the molecular seals of the intestinal barrier, and GEP restored both, outperforming vitamin E. This barrier repair is central to the proposed mechanism: a leaky aging gut allows lipopolysaccharide to enter the bloodstream, cross the blood–brain barrier, and activate TLR4/NF-κB signaling in microglia, driving neuroinflammation and cognitive decline. By resealing the gut, GEP may block this endotoxin traffic at its source.

The authors are candid about the implications and the limitations. Because GEP’s 314-kilodalton size prevents it from crossing an intact blood–brain barrier, its primary target must be the gastrointestinal tract, with brain protection arriving indirectly through the gut–brain axis, possibly via short-chain fatty acids and other microbial metabolites that the study did not measure directly. The work also lacked glycosidic linkage analysis by methylation and two-dimensional NMR, which would clarify how the polysaccharide’s structure governs its fermentability by taxa like Akkermansia, and the findings rest on mice aged twenty months, leaving older cohorts untested. Even so, the convergence of evidence across worms, cells, and mice, spanning behavior, histology, redox biochemistry, inflammatory signaling, microbiome sequencing, and barrier integrity, makes a compelling case that a single natural polysaccharide can coordinate oxidative stress, inflammation, and gut ecology simultaneously. As populations worldwide age and the search for safe multi-target interventions intensifies, GEP’s demonstration that a large, indigestible sugar molecule can protect the brain by way of the gut may prove to be the study’s most enduring insight.

Subject of Research: Anti-aging effects of Gastrodia elata polysaccharide via oxidative stress, inflammation, and gut microbiota modulation

Article Title: Gastrodia elata Polysaccharide Attenuates Aging by Modulating Oxidative Stress, Inflammation, and Gut Microbiota

Article References: Shi, H., Yang, S., Chen, Y., Shaog, B., Gong, R., & Li, Z. (2026). Gastrodia elata Polysaccharide Attenuates Aging by Modulating Oxidative Stress, Inflammation, and Gut Microbiota. Food Science & Nutrition, 14(10), Article e72413. https://doi.org/10.1002/fsn3.72413

Image Credits: AI Generated

DOI: 10.1002/fsn3.72413

Keywords: Gastrodia elata, polysaccharide, aging, oxidative stress, Nrf2/Keap1, TLR4/NF-κB, gut microbiota, intestinal barrier, BDNF, Caenorhabditis elegans, inflammaging, gut-brain axis

Carbon dots are quasi-zero-dimensional carbon nanomaterials, typically smaller than ten nanometers, that have attracted intense interest for their photoluminescence, ease of surface functionalization, and low toxicity. In recent years, biomass has emerged as a sustainable and cost-effective feedstock for these nanoparticles, offering renewable supply chains and greener synthesis routes compared with synthetic molecular precursors. Yet crude biomass presents a fundamental problem. Composed of mixtures of polysaccharides, proteins, organic acids, and other constituents, it triggers competing reactions during carbonization, yielding structurally heterogeneous products with batch-to-batch variability. That heterogeneity translates into uneven distributions of anchoring sites on the resulting dots, which in turn causes uncontrolled aggregation of metal nanoparticles and poor signal reproducibility in the final SERS substrates.

The research team, led by Chengwei Hu and corresponding author Hong Bi of Anhui University, sidestepped this problem by starting from a structurally well-defined biomacromolecule rather than crude plant matter. Polygonatum cyrtonema Hua polysaccharide, abbreviated PcH, was extracted from dried rhizomes using hot-water extraction followed by ethanol precipitation, deproteinization, decolorization, dialysis, and lyophilization. Mass spectrometric analysis revealed a glucan-type backbone with a regular 162-dalton interval between dominant peaks, corresponding to hexose units, while chromatographic analysis of the acid hydrolysate confirmed glucose as the predominant monosaccharide. The polymer showed a moderately polydisperse population of oligomers with degrees of polymerization of roughly eight to sixteen, and thermogravimetric analysis demonstrated thermal stability up to about 300 degrees Celsius, a property that proved essential for the hydrothermal steps to follow.

The key innovation lies in what the researchers did next. Rather than carbonizing the polysaccharide directly, they first oxidized it selectively with sodium periodate under acidic conditions, converting vicinal diols into dialdehyde functionalities. Quantification using the Schiff reagent method showed the relative oxidation degree jumping from 1.26 percent in the pristine polysaccharide to 96.62 percent in the oxidized product, a near-complete conversion. The dialdehyde intermediate was then condensed with L-lysine, an amino acid whose primary amines react with the aldehyde groups to form imine linkages, the hallmark of Schiff-base chemistry. Nuclear magnetic resonance spectroscopy confirmed the formation of these -C=N- bonds with a characteristic resonance near 8.3 parts per million, while infrared spectroscopy showed the carbonyl band near 1720 wavenumbers weakening as a new band emerged around 1650 to 1680 wavenumbers, consistent with C=N stretching.

These imine motifs are far more than decorative. Nitrogen atoms in imine groups carry lone pairs of electrons embedded in an extended pi-conjugated system, making them excellent coordination sites for metal ions. Crucially, the team demonstrated that these functionalities survive the subsequent hydrothermal carbonization, in which the Schiff-base-functionalized precursor was heated at 160 degrees Celsius for six hours in a sealed autoclave. The resulting carbon dots, termed PcH-CDs, emerged as uniformly dispersed quasi-spherical particles averaging about 2.5 nanometers in diameter, with lattice fringes of roughly 0.20 nanometers corresponding to the (100) plane of graphitic carbon. X-ray diffraction showed the amorphous polysaccharide peak at 22 degrees shifting to 26 degrees after carbonization, indicative of a graphite-like sp2-conjugated framework, while Raman spectroscopy revealed the ratio of disorder to graphitic band intensities dropping from 1.59 to 0.75, signaling increased structural ordering.

With the imine sites preserved on the carbon dot surfaces, the researchers introduced silver through a silver-ammonia complex reduction. The surface-exposed -C=N- groups selectively coordinated silver ions, guiding uniform in-situ nucleation and suppressing the random aggregation that plagues conventional syntheses. Transmission electron microscopy showed the hybrid nanoparticles growing to an average of 13.23 nanometers, with silver nanocrystals of roughly 7 to 10 nanometers estimated from X-ray diffraction line broadening. X-ray photoelectron spectroscopy delivered perhaps the most telling evidence: the silver 3d binding energies in the hybrid were blue-shifted by 0.80 electron volts relative to silver nitrate, a shift attributable to strong coordination between silver and the imine nitrogen, which acts as a stronger electron donor than oxygen and withdraws electron density from the metal center. A control sample prepared from unmodified polysaccharide, lacking these nitrogen sites, showed only minor shifts characteristic of weaker silver-oxygen coordination and exhibited markedly weaker silver diffraction peaks.

The practical payoff came in SERS testing. When Rhodamine B was applied to the PcH-CDs-Ag substrate, the characteristic Raman peak at 1650 wavenumbers remained clearly visible down to a concentration of 1 x 10^-10 molar, with a linear calibration spanning ten^-10 to ten^-6 molar and a correlation coefficient of 0.99. The calculated enhancement factor reached 4.21 x 10^6, roughly three orders of magnitude higher than that of metal-free nitrogen-doped graphene quantum dots for the same analyte. Signal reproducibility, measured across twenty randomly selected points on a single substrate, yielded a relative standard deviation of 11.7 percent, an acceptable figure for practical analytical work. The substrate also proved durable: after six weeks of ambient storage, SERS intensities retained approximately 70 percent of their initial values, with the carbon dot matrix apparently protecting the silver nanoparticles from oxidation. Methylene blue served as a second probe molecule, detectable down to 1 x 10^-8 molar, confirming the platform’s versatility beyond a single analyte.

To understand why the nitrogen-coordinated system outperforms its oxygen-coordinated counterpart, the team turned to density functional theory. Optimized geometries showed an Ag-N bond length of 1.97 angstroms, significantly shorter than the 2.14-angstrom Ag-O bond, indicating a stronger and more localized interaction. Natural bond orbital analysis quantified the difference dramatically: the donor-acceptor interaction from the imine pi bond to the silver acceptor orbital exhibited a second-order stabilization energy of 71.6 kilocalories per mole with an orbital occupation number of 0.39639, whereas the corresponding oxygen-to-silver interaction registered below 3 kilocalories per mole with an occupation number of just 0.01314. The Ag-N system also displayed a substantially narrowed band gap of 1.63 electron volts compared with 3.46 electron volts for Ag-O, conditions that favor excited-state charge transfer across the molecule-metal interface and amplify the chemical enhancement contribution to the SERS signal.

Beyond the immediate analytical performance, the study carries a broader message about how natural polysaccharides can be used in materials design. The authors argue that glycans should be viewed not merely as sustainable carbon sources but as chemically tunable platforms whose repeating-unit backbones and abundant hydroxyl groups allow precise, site-specific molecular modification. By combining regioselective oxidation, Schiff-base condensation, hydrothermal carbonization, and coordination-directed metal deposition, the researchers demonstrated a molecular route to controllable carbon-metal hybrid nanoparticles in which interfacial chemistry, rather than chance, dictates performance. The aqueous processability of the hybrid, along with its uniform silver loading, suggests suitability for coating onto flexible substrates, opening possibilities for lightweight, portable SERS devices for environmental monitoring, food safety testing, and trace detection of organic pollutants. Extending this strategy to other polysaccharide systems, the team suggests, could open new avenues for sustainable materials in advanced sensing applications, turning an ancient medicinal plant into a blueprint for next-generation nanosensors.

Subject of Research: Schiff-base-functionalized carbon dots derived from Polygonatum cyrtonema Hua polysaccharide decorated with silver nanoparticles for surface-enhanced Raman scattering detection of trace organic pollutants

Article Title: Silver decorated Schiff base functionalized carbon dots derived from Polygonatum cyrtonema Hua polysaccharide for surface enhanced Raman scattering

Article References: Hu, C., Zhu, H., Cui, J., Xue, J., Liu, J., Liu, C., & Bi, H. (2026). Silver decorated Schiff base functionalized carbon dots derived from Polygonatum cyrtonema Hua polysaccharide for surface enhanced Raman scattering. Discover Green Chemistry, 1(1), Article 23. https://doi.org/10.1007/s44509-026-00024-0

Image Credits: AI Generated

DOI: 10.1007/s44509-026-00024-0

Keywords: carbon dots, SERS, Polygonatum cyrtonema Hua, polysaccharide, Schiff base, silver nanoparticles, surface-enhanced Raman scattering, biomass, green chemistry, Rhodamine B, density functional theory, nanosensors

The scale of the underlying problem is enormous. According to figures cited in the study, roughly 828 million people worldwide were living with diabetes in 2022, with type 2 diabetes accounting for 96 percent of cases. MASLD, a spectrum of liver disease ranging from simple fatty liver to inflammation, fibrosis, cirrhosis, and even liver cancer, now affects an estimated 39 percent of the global population and is increasingly diagnosed in younger people. Critically, the two diseases are frequent companions: epidemiological studies suggest that up to 65 percent of patients with type 2 diabetes also have MASLD. They share a common pathological root in disordered glucose and lipid metabolism, and each worsens the other in a self-reinforcing cycle that accelerates cardiovascular and liver complications.

Current treatment options for this comorbidity remain limited. Weight loss through lifestyle change is the foundation of therapy for both conditions, but its effects are often insufficient on their own. Hypoglycemic drugs, newer injectable agents, and bariatric surgery show promise, yet safe and effective interventions designed specifically for diabetes-associated MASLD are still lacking. This therapeutic gap motivated the research team to look toward edible-medicinal plants, a traditional source of bioactive compounds, and in particular toward Polygonatum cyrtonema Hua, a tonic herb long used in Chinese medicine for its purported benefits in diabetes and hyperlipidemia. While polysaccharides are recognized as the herb’s major active constituents, their specific effects and mechanisms in diabetes-related liver disease had remained unclear.

The team isolated and purified the polysaccharide fraction they named PCP III from dried rhizomes using ethanol pretreatment, hot-water extraction, and stepwise ethanol precipitation. Characterization revealed a molecule with distinctive physical properties: a total sugar content of 90.76 percent, a modest protein content of about 6 percent, and a remarkably low average molecular weight of approximately 2.4 kilodaltons. Chromatographic analysis of its monosaccharide building blocks showed that fructose and glucose dominate the composition, accounting for roughly 65 and 33 percent respectively, with smaller amounts of galactose, glucosamine, arabinose, and galactosamine. Infrared spectroscopy confirmed the classic polysaccharide fingerprint of hydroxyl, carbon-hydrogen, and glycosidic bond vibrations. The researchers suggest that the compound’s low molecular weight may facilitate absorption or interaction with gut epithelial cells compared with larger polysaccharides, potentially contributing to its biological activity.

To test the compound’s effects, the researchers used a well-established mouse model that mimics the progressive nature of human disease. Young male C57BL/6J mice were fed a diet deriving 60 percent of calories from fat for eight weeks and then injected with streptozotocin, a chemical that damages insulin-producing cells, to induce type 2 diabetes. Only mice with fasting blood glucose at or above 11.1 millimoles per liter and histologically confirmed fatty liver were included. The diabetic mice were then divided into groups receiving either no treatment, the diabetes drug metformin, the cholesterol-lowering drug atorvastatin, or PCP III at low or high doses of 500 or 1000 milligrams per kilogram of body weight daily for eight weeks.

The results were striking. Untreated diabetic mice gained weight steadily, developed enlarged livers and expanded fat stores, showed persistent hyperglycemia, cleared glucose poorly in tolerance tests, and displayed elevated total cholesterol, triglycerides, and LDL cholesterol along with elevated liver enzymes indicating hepatocellular damage. PCP III treatment attenuated weight gain without reducing food or water intake, lowered fasting blood glucose, improved glucose tolerance, partially corrected the lipid profile with a particularly clear reduction in LDL cholesterol at the high dose, and significantly decreased the liver injury markers gamma-glutamyl transferase, alanine aminotransferase, and aspartate aminotransferase. The compound also lowered serum levels of glycated serum protein and insulin, and reduced the abnormal elevation of both leptin and its soluble receptor, pointing to a partial restoration of leptin-related metabolic regulation.

Direct examination of liver tissue reinforced the biochemical findings. Livers from untreated model mice were visibly enlarged, pale, and greasy, and microscopy revealed swollen hepatocytes crowded with lipid vacuoles and disordered hepatic cords. Oil Red O staining confirmed abundant fat droplet deposition, and ultrasound imaging showed the characteristic brightened liver echo texture, blurred vessel walls, and deep echo attenuation of hepatic steatosis. After PCP III treatment, particularly at the high dose, liver appearance normalized, histological fat accumulation fell, and ultrasonographic abnormalities improved. The compound also rebalanced hepatic oxidative stress, restoring the activities of the antioxidant enzymes superoxide dismutase and glutathione peroxidase and reducing the lipid peroxidation product malondialdehyde, all of which had been deranged by the disease process.

The mechanistic core of the study came from liver transcriptome sequencing combined with validation experiments. Untreated model mice showed 237 differentially expressed genes relative to healthy controls, whereas PCP III intervention altered 1599 genes, revealing an extensive remodeling of the hepatic transcriptional network. Forty-two genes changed in common across comparisons, and pathway analysis pointed squarely at the peroxisome proliferator-activated receptor, or PPAR, signaling pathway, alongside oxidative phosphorylation and steroid biosynthesis. Quantitative PCR and Western blotting confirmed that the compound increased expression of PPAR alpha and its downstream targets involved in fatty acid transport and oxidation, including the transporter Slc27a1 and the bile acid synthesis enzyme CYP7A1, while suppressing PPAR gamma, the lipid droplet protein PLIN2, and the fatty acid binding protein FABP2, which were abnormally elevated in disease. In essence, PCP III appeared to shift the liver away from fat storage and toward fat burning and cholesterol-to-bile-acid conversion.

The gut microbiota emerged as a second, complementary target. Sequencing of bacterial 16S rRNA genes from intestinal contents showed that diseased mice had altered community structure and depleted populations of several beneficial taxa, including members of Muribaculaceae, Clostridia UCG-014, and Dubosiella, while an opportunistic group within Erysipelotrichaceae expanded. High-dose PCP III partially reversed these shifts, restoring the beneficial genera toward the profile seen in healthy mice. Correlation analysis revealed that Clostridia UCG-014 abundance tracked positively with hepatic antioxidant enzyme levels and negatively with serum insulin, leptin, and LDL cholesterol, while Dubosiella was inversely associated with liver injury markers. Gas chromatography-mass spectrometry of cecal contents showed that PCP III also reshaped short-chain fatty acids, raising isohexanoic acid and lowering valeric, isobutyric, isovaleric, and acetic acids. Because short-chain fatty acids absorbed through the portal vein can activate hepatic PPAR alpha and strengthen the gut barrier, the authors propose that microbial remodeling and PPAR modulation form a linked, multi-target network underlying the compound’s benefit.

The authors are careful to note the study’s limitations. No pharmacological antagonist or genetic knockout was used to prove that PPAR signaling is causally required for the effects, so the mechanism remains associative; microbiota and metabolite analyses were limited to the high-dose group; only male mice were studied; the HFD and streptozotocin model does not fully recapitulate human disease; and the fine structural features of the polysaccharide, such as its glycosidic linkages and branching, remain unresolved. Even so, the convergence of phenotypic, histological, transcriptomic, protein-level, microbiological, and metabolomic evidence makes PCP III a compelling candidate for development as a functional food ingredient or nutritional supplement aimed at the metabolic comorbidity of type 2 diabetes and MASLD. Future work validating the findings in clinical cohorts and pinpointing the specific microbial metabolites involved will determine whether a sugar molecule from a humble medicinal rhizome can one day help break the vicious cycle that links two of the world’s fastest-growing chronic diseases.

Subject of Research: A purified polysaccharide from Polygonatum cyrtonema Hua that alleviates type 2 diabetes-associated fatty liver disease by regulating the PPAR pathway and gut microbiota.

Article Title: Polysaccharide III from Polygonatum cyrtonema Hua alleviates diabetes-associated MASLD via PPAR pathway-mediated regulation of lipid metabolism and gut microbiota modulation

Article References: Chen, S., Ren, Z., Guo, Z., Mei, X., Chen, X., Tong, Y., Fan, X., & Dai, G. (2026). Polysaccharide III from Polygonatum cyrtonema Hua alleviates diabetes-associated MASLD via PPAR pathway-mediated regulation of lipid metabolism and gut microbiota modulation. Journal of Agriculture and Food Research, 31, Article 103254. https://doi.org/10.1016/j.jafr.2026.103254

Image Credits: AI Generated

DOI: 10.1016/j.jafr.2026.103254

Keywords: Polygonatum cyrtonema, polysaccharide, MASLD, type 2 diabetes, PPAR signaling, gut microbiota, hepatic steatosis, short-chain fatty acids, insulin resistance, lipid metabolism, functional foods, mouse model